[Skip to Content]
[Skip to Content Landing]
Article
October 1952

News and CommentANNOUNCEMENTS

AMA Am J Dis Child. 1952;84(4):531. doi:10.1001/archpedi.1952.02050040139011

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Jacobi Fund.—The Jacobi Fund of the Section on Pediatrics of the A. M. A. received $1,696 from 282 contributors, according to the report made at the June meeting in Chicago by Hugh L. Dwyer, M.D., Custodian. Net income from investments was $188.76. Expense and distribution to essayists was $731.80. Trust value May 30, 1952, was $6,890.04.

Revised Labeling of Chloramphenicol (chloromycetin®).—The Food and Drug Administration of the Federal Security Agency announced today its decision to permit the continued distribution of the antibiotic drug chloramphenicol under revised labeling that will caution physicians explicitly against its indiscriminate use.

Caution  Certain blood dyscrasias (aplastic anemia, thrombocytopenic purpura, granulocytopenia and pancytopenia) have been associated with the administration of chloramphenicol. It is essential that adequate blood studies be made when prolonged or intermittent administration of this drug is required. Chloramphenicol should not be used indiscriminately or for minor infections.Blood dyscrasias may be

First Page Preview View Large
First page PDF preview
First page PDF preview
×